JPMorgan Funds - Thematics - Genetic Therapies C2 (dist) - CHF (hedged)/  LU2053353749  /

Fonds
NAV05/06/2024 Var.+0.0900 Type of yield Focus sugli investimenti Società d'investimento
90.8200CHF +0.10% paying dividend Equity JPMorgan AM (EU)